Life Science Washington
Life Science Washington is the trade association for Washington state's life science companies and organizations.
Facts
- HQ
- Seattle
- Sectors
- Industry Associations
- Founded
- 1989
- Employees
- 32
Is this your organization? Claim it
AWS Launches $100M, Five-Year Health Impact Initiative to Supply AI and Cloud Tools to Organizations Closing Global Health Gaps
AWS announced a five-year, $100 million Health Impact Initiative providing AI, agentic services, and cloud infrastructure to nonprofits, researchers, governments, and companies working to close health gaps for underserved populations. The program targets diagnostics and research access, women’s and children’s health data gaps, and nutrition, and builds on prior support for more than 600 health organizations.
UW Institute for Protein Design and Nvidia unveil AI model to design function-specific proteins, accelerating drug discovery and biotech
UW Institute for Protein Design and Nvidia have jointly released an AI model to help researchers design proteins with specific functions, aiming to speed drug discovery and biotech applications while highlighting Washington’s role in AI-driven life sciences.
Mary Brunkow, Seattle Researcher, Wins Share of 2025 Nobel for Discovery of Immune Self-Tolerance Gene
Mary Brunkow, a researcher at Seattle’s Institute for Systems Biology, helped discover how the immune system prevents self-attack—a finding that earned her a share of the 2025 Nobel Prize in Physiology or Medicine and could advance autoimmune disease treatments.
Jonathan Kil, MD of Sound Pharmaceuticals Discusses Company Journey and Therapies Targeting Hearing Loss
Jonathan Kil, MD, CEO of Sound Pharmaceuticals, discusses the company’s scientific progress, plans, and Washington ecosystem support in a conversation with Life Science Washington’s Marc Cummings, highlighting efforts to develop new therapies for hearing loss.
Genmab’s $1.8B ProfoundBio Acquisition Yields Positive Phase 3 Results for Rina-S in Platinum-Resistant Ovarian Cancer
Genmab's recently acquired drug rinatabart sesutecan (Rina-S) showed significant improvements in progression-free and overall survival in a Phase 3 trial for patients with platinum-resistant ovarian cancer. The drug was part of Genmab's $1.8 billion acquisition of Seattle-based ProfoundBio.
Three Fred Hutch Researchers Receive American Cancer Society Grants to Study Cancer Metabolism and Rare Liver Cancers
Three Fred Hutch Cancer Center researchers received American Cancer Society funding to study cancer metabolism and rare liver cancers, aiming to improve understanding of tumor development and identify precision-medicine approaches for hard-to-treat cases.
Washington State University Wins $7.5M Federal Grant to Study Kratom’s Effects on Chronic Pain and Sleep
Washington State University won a $7.5 million federal grant to fund a multi-year study of kratom’s effects on chronic pain and sleep, evaluating its potential benefits and risks amid growing interest in alternative pain management.
Life Science Washington, Greater Spokane Inc., LaunchPad INW and Health Sciences & Services Authority Form Alliance to Boost Eastern Washington Life-Science Entrepreneurship
A coalition of Life Science Washington, Greater Spokane Incorporated, LaunchPad INW, and the Health Sciences & Services Authority of Spokane County will collaborate to broaden mentorship, funding, and commercialization support for life science entrepreneurs across Eastern Washington.
Roche Licenses Zymeworks’ ZW209 Lung Cancer Therapy in Deal Worth Up to $813M
Zymeworks licensed its experimental lung cancer therapy ZW209 to Roche in a deal that could be worth up to $813 million, providing funding as Zymeworks advances its next-generation cancer treatment platform.
Bristol Myers Squibb Reports Five Positive Phase 3 Trials for SystImmune‑Developed ADC Iza‑Bren Showing Benefits in Lung and Breast Cancer
Bristol Myers Squibb reports five positive Phase 3 trials for Iza-Bren, an antibody-drug conjugate developed by SystImmune, showing improved outcomes in certain lung and breast cancers and supporting its broader global development.
Seattle Children’s launches $10M Institute for Pediatric Innovation to advance AI, precision medicine, and genomics
Seattle Children’s launched a $10 million Institute for Pediatric Innovation to accelerate advances in AI, precision medicine, and genomic sequencing and to drive the hospital’s strategy for improving pediatric outcomes at scale.
Pacific Northwest National Laboratory breaks ground on autonomous biosciences facility in Richland with 100+ automated instruments
Pacific Northwest National Laboratory is building a publicly accessible autonomous biosciences facility in Richland with over 100 automated instruments to accelerate large-scale microbial research for academic, industry, and government scientists.
Sound Pharmaceuticals’ SPI-1005 Improves Hearing and Speech Understanding in Phase 3 Trial of 221 Ménière’s Patients; ~33% Show Meaningful Gain
Sound Pharmaceuticals reported Phase 3 results for oral candidate SPI-1005 in 221 adults with Ménière’s disease, showing improvements in hearing and speech understanding versus placebo and about one-third of treated patients achieving meaningful hearing gains after 84 days.
UW Institute for Protein Design Uses AI to Create Proteases That Cut Alzheimer’s and ALS-Linked Proteins
Researchers at the University of Washington’s Institute for Protein Design used in-house AI models to design novel protease proteins that selectively cut disease-linked proteins implicated in Alzheimer’s and ALS, functioning like molecular scissors to target and degrade those proteins.
TwinStrand Biosciences and University of Washington Win $245.2M Judgment; Guardant Health Must Pay 6% Royalty Through 2033
TwinStrand Biosciences and the University of Washington won a $245.2 million patent infringement judgment against Guardant Health over UW-developed DNA sequencing technology, with a court upholding a 2023 jury verdict and requiring Guardant to pay a 6% royalty on covered products through 2033.
Curi Bio Expands Curiverse with Disease-Specific iPSC Models, Casting Kits, and Assays for Cardiac, Skeletal Muscle, and Neuromuscular Research
Curi Bio expanded its Curiverse ecosystem to offer disease-specific iPSC models, casting kits, validated assays, and integrated research services for cardiac, skeletal muscle, and neuromuscular applications, enabling researchers to accelerate human-relevant drug discovery without building models in-house.
Washington Research Foundation Awards $272,500 to UW’s Aman Garg to Advance FlexLock Guide Catheter
Washington Research Foundation granted $272,500 to University of Washington research engineer Aman Garg to advance the FlexLock Guide Catheter, following a $110,000 phase 1 award, to improve safety and efficiency in complex heart procedures.
University of Washington Uses DNA Typewriter to Reconstruct Cell Lineage from First Division Through Organ Formation in Mouse Embryo
Researchers at the University of Washington used DNA Typewriter technology to reconstruct the lineage of cells in a developing mouse embryo, tracing relationships from the first cell division through organ formation. The study, featuring co-first authors from the Seattle Hub for Synthetic Biology, was published in Science and represents a major milestone for the Hub.
Andy Hill CARE Fund Appoints Molly O’Connor as Executive Director Effective September 28, 2026
The Andy Hill Cancer Research Endowment names Molly O’Connor as its new Executive Director, bringing leadership and a vision to continue CARE’s progress.
Washington Research Foundation Awards $272,500 to UW Engineer Aman Garg to Advance FlexLock Guide Catheter
WRF awarded Aman Garg a $272,500 Phase 2 commercialization grant to advance the FlexLock Guide Catheter, aiming to make complex heart procedures safer and more efficient.
UW Medicine Institute for Protein Design Secures Nearly 7M GPU Hours from Jen-Hsun and Lori Huang Foundation
The UW Medicine Institute for Protein Design, led by Nobel laureate David Baker, received nearly 7 million GPU hours from the Jen-Hsun and Lori Huang Foundation to speed development of open-source AI models for protein design.
Life Science Washington, HSSA Spokane County, Greater Spokane Inc. and LaunchPad INW partner to boost Spokane life‑science startups
Life Science Washington, HSSA of Spokane County, Greater Spokane Inc., and LaunchPad INW formed a partnership to coordinate funding, startup resources, and statewide networks to support life science entrepreneurs and relocating companies in the greater Spokane region. The collaboration will provide tailored services — including mentoring, grant and investor support, and executive programming — to help early-stage companies commercialize and grow in Spokane.
Seattle Ranks No. 4 Globally, No. 2 in U.S. on Oxford Economics’ 2026 Global Cities Index
Seattle is a leading life sciences hub and ranks No. 2 in the U.S. and No. 4 globally on Oxford Economics’ 2026 Global Cities Index, reflecting its strong economy, skilled workforce, and quality of life that support innovation and company growth.
University of Washington Breaks Ground on $231.1M Chemistry Sciences Building; State Pledges $129M
UW broke ground on a $231.1M, five-story Chemistry Sciences Building in Seattle to house research and teaching labs in human health, sustainable chemistry, advanced materials and quantum science, with state funding of $129M and the rest from UW and private donors. The facility, aimed at workforce training and industry collaboration to attract and retain students and researchers, is expected to open in 2029.
WSU Researcher Santanu Bose Wins $3.04M NIH Grant to Study Immune-Driven Lung Damage from RSV
WSU researcher Santanu Bose received a $3.04 million, five-year NIH grant to study how the immune response to RSV causes lung-damaging inflammation and to test therapeutic approaches to block that process.
People
-
Marc Cummings Executive, President & CEO